Study of LM-102 in Patients With Advance Solid Tumors
Clinical trial NCT05008445 · TERMINATED
Trial details
- NCT number
- NCT05008445
- Sponsor
- LaNova Medicines Development Co., Ltd.
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-06
- Primary completion
- 2023-02-08
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.